Hongbo Lu's Trading History
| ARWRArrowhead Pharmaceuticals | May 14, 2026 | Director | Uninformative Sell | 228.33K | $3.12M | |
| ZBIOZenas BioPharma, Inc. | Apr 02, 2026 | Director | Informative Buy | 70.20K | $12.12M | |
| TERNTerns Pharmaceuticals | Sep 17, 2024 | ― | Informative Buy | 5.00M | $25.21M | |
| TPTXTurning Point Therapeutics | Apr 24, 2019 | ― | Uninformative Buy | ― | $131.31M | |
| ~AVDRAvedro | ― | ― | ― | ― |
You May Also Like
Hongbo Lu insider profile FAQ
What is the percentage of profitable transactions made by Hongbo Lu?
The percentage of profitable transactions made by Hongbo Lu is 64%.
What is the average return per transaction made by Hongbo Lu?
The average return per transaction made by Hongbo Lu is 11.50%.
What stocks does Hongbo Lu hold?
Hongbo Lu holds: ZBIO, ARWR, ~AVDR, TPTX, TERN stocks.
What was Hongbo Lu’s latest transaction?
Hongbo Lu’s latest transaction was an Uninformative Sell of $228.33K.
What was Hongbo Lu's most profitable transaction?
Hongbo Lu’s most profitable transaction was an Informative Buy of TPTX stock on April 24, 2019. The return on the trade was 83.20%.
What is Hongbo Lu's role in Zenas BioPharma, Inc.?
Hongbo Lu's role in Zenas BioPharma, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.